133 related articles for article (PubMed ID: 10896122)
21. Synthesis and biological evaluation of a targeted library of protein phosphatase inhibitors.
Wipf P; Aslan DC; Luci DK; Southwick EC; Lazo JS
Biotechnol Bioeng; 2000; 71(1):58-70. PubMed ID: 10629537
[TBL] [Abstract][Full Text] [Related]
22. Syntheses and biological activities of a novel group of steroidal derived inhibitors for human Cdc25A protein phosphatase.
Peng H; Xie W; Otterness DM; Cogswell JP; McConnell RT; Carter HL; Powis G; Abraham RT; Zalkow LH
J Med Chem; 2001 Mar; 44(5):834-48. PubMed ID: 11262093
[TBL] [Abstract][Full Text] [Related]
23. Coscinosulfate, a CDC25 phosphatase inhibitor from the sponge Coscinoderma mathewsi.
Loukaci A; Le Saout I; Samadi M; Leclerc S; Damiens E; Meijer L; Debitus C; Guyot M
Bioorg Med Chem; 2001 Nov; 9(11):3049-54. PubMed ID: 11597488
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of novel thiadiazole amides as potent Cdc25B and PTP1B inhibitors.
Li Y; Yu Y; Jin K; Gao L; Luo T; Sheng L; Shao X; Li J
Bioorg Med Chem Lett; 2014 Sep; 24(17):4125-8. PubMed ID: 25124112
[TBL] [Abstract][Full Text] [Related]
25. Synthetic small molecule Cdc25 phosphatases inhibitors.
Garuti L; Roberti M; Pizzirani D
Curr Med Chem; 2008; 15(6):573-80. PubMed ID: 18336271
[TBL] [Abstract][Full Text] [Related]
26. Chalcones derivatives as potent Cell division cycle 25B phosphatase inhibitors.
Zhang J; Ji FJ; Gu Y; Zhang XY; Qiao SX
Pharmacol Rep; 2014 Jun; 66(3):515-9. PubMed ID: 24905533
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and biological evaluation of 3-aminoisoquinolin-1(2H)-one based inhibitors of the dual-specificity phosphatase Cdc25B.
George Rosenker KM; Paquette WD; Johnston PA; Sharlow ER; Vogt A; Bakan A; Lazo JS; Wipf P
Bioorg Med Chem; 2015 Jun; 23(12):2810-8. PubMed ID: 25703307
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of miltirone analogues as inhibitors of Cdc25 phosphatases.
Huang W; Li J; Zhang W; Zhou Y; Xie C; Luo Y; Li Y; Wang J; Li J; Lu W
Bioorg Med Chem Lett; 2006 Apr; 16(7):1905-8. PubMed ID: 16434190
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and biological evaluation of caulibugulones A-E.
Wipf P; Joo B; Nguyen T; Lazo JS
Org Biomol Chem; 2004 Aug; 2(15):2173-4. PubMed ID: 15280951
[TBL] [Abstract][Full Text] [Related]
30. EK-6136 (3-methyl-4-(O-methyl-oximino)-1-phenylpyrazolin-5-one): a novel Cdc25B inhibitor with antiproliferative activity.
Kim KR; Kwon JL; Kim JS; No Z; Kim HR; Cheon HG
Eur J Pharmacol; 2005 Dec; 528(1-3):37-42. PubMed ID: 16324698
[TBL] [Abstract][Full Text] [Related]
31. Design, synthesis, and biological evaluation of novel naphthoquinone derivatives with CDC25 phosphatase inhibitory activity.
Brun MP; Braud E; Angotti D; Mondésert O; Quaranta M; Montes M; Miteva M; Gresh N; Ducommun B; Garbay C
Bioorg Med Chem; 2005 Aug; 13(16):4871-9. PubMed ID: 15921913
[TBL] [Abstract][Full Text] [Related]
32. Novel naphthoquinone and quinolinedione inhibitors of CDC25 phosphatase activity with antiproliferative properties.
Braud E; Goddard ML; Kolb S; Brun MP; Mondésert O; Quaranta M; Gresh N; Ducommun B; Garbay C
Bioorg Med Chem; 2008 Oct; 16(19):9040-9. PubMed ID: 18789703
[TBL] [Abstract][Full Text] [Related]
33. Discovery and structural optimization of pyrazole derivatives as novel inhibitors of Cdc25B.
Chen HJ; Liu Y; Wang LN; Shen Q; Li J; Nan FJ
Bioorg Med Chem Lett; 2010 May; 20(9):2876-9. PubMed ID: 20363629
[TBL] [Abstract][Full Text] [Related]
34. Inhibition mechanism of naphthylphenylamine derivatives acting on the CDC25B dual phosphatase and analysis of the molecular processes involved in the high cytotoxicity exerted by one selected derivative in melanoma cells.
Aliotta F; Nasso R; Rullo R; Arcucci A; Avagliano A; Simonetti M; Sanità G; Masullo M; Lavecchia A; Ruocco MR; Vendittis E
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1866-1878. PubMed ID: 32990107
[TBL] [Abstract][Full Text] [Related]
35. Design and synthesis of novel bis-thiazolone derivatives as micromolar CDC25 phosphatase inhibitors: effect of dimerisation on phosphatase inhibition.
Sarkis M; Tran DN; Kolb S; Miteva MA; Villoutreix BO; Garbay C; Braud E
Bioorg Med Chem Lett; 2012 Dec; 22(24):7345-50. PubMed ID: 23141909
[TBL] [Abstract][Full Text] [Related]
36. CDC25A and B dual-specificity phosphatase inhibitors: potential agents for cancer therapy.
Lavecchia A; Di Giovanni C; Novellino E
Curr Med Chem; 2009; 16(15):1831-49. PubMed ID: 19442149
[TBL] [Abstract][Full Text] [Related]
37. Design and synthesis of new potent PTP1B inhibitors with the skeleton of 2-substituted imino-3-substituted-5-heteroarylidene-1,3-thiazolidine-4-one: Part I.
Meng G; Zheng M; Wang M; Tong J; Ge W; Zhang J; Zheng A; Li J; Gao L; Li J
Eur J Med Chem; 2016 Oct; 122():756-769. PubMed ID: 27526040
[TBL] [Abstract][Full Text] [Related]
38. NAD(P)H:quinone oxidoreductase-1-dependent and -independent cytotoxicity of potent quinone Cdc25 phosphatase inhibitors.
Han Y; Shen H; Carr BI; Wipf P; Lazo JS; Pan SS
J Pharmacol Exp Ther; 2004 Apr; 309(1):64-70. PubMed ID: 14718602
[TBL] [Abstract][Full Text] [Related]
39. Four diterpenoid inhibitors of Cdc25B phosphatase from a marine anemone.
Cao S; Foster C; Lazo JS; Kingston DG
Bioorg Med Chem; 2005 Oct; 13(20):5830-4. PubMed ID: 15993607
[TBL] [Abstract][Full Text] [Related]
40. Independent mechanistic inhibition of cdc25 phosphatases by a natural product caulibugulone.
Brisson M; Foster C; Wipf P; Joo B; Tomko RJ; Nguyen T; Lazo JS
Mol Pharmacol; 2007 Jan; 71(1):184-92. PubMed ID: 17018577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
